CATEGORIES

Boston Scientific launches AVVIGO+ Multi-Modality guidance system in India

Boston Scientific Corporation has announced the launch of AVVIGO+ Multi-Modality Guidance System, a next-generation intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system with advanced software and hardware features designed to provide high-quality IVUS vessel imaging and physiology experience during percutaneous coronary intervention (PCI) procedures.

WHO prequalifies Zydus's Typhoid Vi Conjugate Vaccine, ZyVac TCV

Zydus Lifesciences has received in principle acceptability from the World Health Organisation (WHO) for ZyVac TCV.

Bain Capital-backed 360 ONE Asset Management invests in A4 Hospitals

360 ONE’s Healthcare Opportunities Fund has entered into definitive agreements to invest in A4 Hospitals, a prominent integrated women’s healthcare chain based in Tamil Nadu, with a robust presence in Chennai.

OneSource Specialty Pharma receives equity commitments of Rs 801 Cr from marquee investors

Strides Pharma Science has announced that its associate company, OneSource Specialty Pharma (formerly known as Stelis Biopharma), Group’s Specialty Pharma CDMO (contract development and manufacturing organisation), has received confirmed commitments for fundraising of Rs 801 crore (~$95 million) from marquee domestic and foreign institutional investors and family offices, in the pre-listing round.

NPPA revises ceiling prices of 8 scheduled drugs

The National Pharmaceutical Pricing Authority (NPPA) has been receiving applications from the manufacturers for upward revision of prices citing various reasons like increased cost of Active Pharmaceutical Ingredients; increase in the cost of production; change in exchange rate etc.; resulting in unviability in sustainable production and marketing of drugs.

NPPA directs companies to reduce MRP on 3 anti-cancer drugs

In line with the government’s commitment to ensure the availability of drugs at affordable prices, National Pharmaceutical Pricing Authority (NPPA) has issued an O.M. dated October 28, 2024 directing the concerned manufacturers to reduce the Maximum Retail Price (MRP) on three anti-cancer drugs, Trastuzumab, Osimertinib and Durvalumab.

Govt unveils 5 pioneering health research initiatives for medical innovation

Union Health Minister Jagat Prakash Nadda launched five Department of Health Research- Indian Council of Medical Research (DHR-ICMR) health research initiatives planned under the 100 days agenda.

Punjab unveils Stroke Care Model in partnership with CMC Ludhiana and Medtronic

Punjab Health Minister Dr Balbir Singh has announced a transformative collaboration between the Government of Punjab, Christian Medical College (CMC) Ludhiana, and India Medtronic Private Limited.

HIV Prevention Remains Elusive

On December 1, the world gathers every year to commemorate World AIDS Day, which serves as an important reminder that we must remain steadfast in our commitment to prevent new HIV (Human Immunodeficiency Virus) infections and provide essential services to all people living with HIV globally.

Bengaluru Tech Summit 2024 Karnataka launches India's first GCC policy

The 27th Edition of Bengaluru Tech Summit (BTS) 2024, organised by the Department of Electronics, IT, Bt, Government of Karnataka and Software Technology Parks of India, Bengaluru, was inaugurated by Siddaramaiah, Chief Minister of Karnataka, in the august presence of other dignitaries, at Bangalore Palace on November 19.

Innovations in Urological Imaging: Transforming Patient Care in India

Despite advancements in urological imaging, challenges persist in India, particularly regarding cost and accessibility. Government initiatives and public-private partnerships should expand access to imaging facilities. Continued research investment is crucial for developing cost-effective solutions.

How strategic angel investment is driving global expansion in medtech and diagnostics

India has firmly established itself as a key player in the global medtech and diagnostics sectors. With a burgeoning healthcare ecosystem and a growing focus on innovation, the country offers a fertile ground for startups looking to scale their solutions both domestically and internationally. Central to this growth is the role of strategic angel investment, which not only provides financial backing but also offers critical mentorship and strategic direction to help these companies expand their reach.

How To Control Indian Diabetes Growth

World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.

What's dampening the GLOBAL AMR BATTLE?

Although there have been significant national and worldwide efforts to provide financial incentives for antibiotic research and development, it is still unclear how best to fortify the existing programmes to further spur antibiotic innovation.

Indian Lifesciences Industry Going Ahead in its Innovation Journey While Navigating Challenges

While India is a hub for biosimilar manufacturing and continues to build its capabilities to manufacture these complex therapeutics, Indian biopharma companies are building R&D capabilities and establishing public-private collaborations and Centre of Excellences (CoEs) to develop innovative biologics and advanced therapeutic modalities like cell and gene therapy (CGT) and mRNA vaccines and therapies, biopharma sector remained robust in 2023, accounting for $53.8 billion (35 per cent of the BioEconomy).

BioPharma's Transformative & Strategic OUTLOOK 2025

The Indian biopharma industry witnessed notable transformative developments and announcements, marked by innovation, regulatory advancements, and market expansion this year.

Early Diabetic Retinopathy Detection Remains a Challenge

The Vitreo Retinal Society of India (VRSI) and the Research Society for the Study of Diabetes in India (RSSDI) have formulated a first-of-its kind diabetic retinopathy (DR) screening guideline to help physicians and diabetologists in India educate their patients about DR.

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology

Qiagen N.V. has announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfolio now expanding into clinical diagnostics.

Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis

Thermo Fisher Scientific Inc. has launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS).

Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

IIT Madras identifies enhanced drug delivery method for eye treatments

Researchers at the Indian Institute of Technology Madras (IIT-M) have demonstrated how drugs injected in the human eye can be better delivered to the target region through ‘convection caused by mild laser heating’.

IIT Madras develops indigenous POCUS scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-Care-Ultrasound (POCUS) Scanner for sports injury diagnosis and management.

Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla

Practo has appointed two new directors to its board: TVG Krishnamurthy and Dr Alexander Kuruvilla.

Dr R N Gupta steps in as National President of Indian Pharmaceutical Association

Dr R N Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA), the oldest and largest association of pharmaceutical professionals in the country, for the term 2024 - 2026 (October 1, 2024 - September 30, 2026).

QR678 brings medtech leader Sridhar Ranganathan to advisory board

QR678, a pioneering company dedicated to revolutionising hair and skin science through groundbreaking research and innovative solutions, has announced the appointment of Sridhar Ranganathan to its Board of Advisors.

Victor Ambros and Gary Ruvkun win 2024 Nobel Prize in Physiology or Medicine for discovery of microRNA

The Nobel Assembly at Karolinska Institutet has decided to award the 2024 Nobel Prize in Physiology or Medicine jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Bhushan Akshikar steps in as OPPI President

The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in India, has appointed Bhushan Akshikar as its President for a term of two years effective September 26, 2024.

Integris appoints medtech veteran Probir Das as new CEO

Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO).

IIIT Hyderabad offers AI-based online courses for medical professionals

International Institute of Information Technology Hyderabad (IIIT-H) has launched an online course on 'AI for Medical Professionals', in collaboration with National Academy of Medical Sciences (NAMS), an autonomous organisation under the Ministry of Health & Family Welfare, Government of India, and IHub-Data.